EUVIMEDObjevte EUVIMED
Multizentrische StudieOpen access · CC BY-NC-ND 4.0

Noncoronary Sinus Pivot Implantation (NCPI) Strategy for Transcatheter Aortic Valve Replacement With Self‐Expanding Valve in Pure Native Aortic Regurgitation: A Multicenter, Registry Study From the CCA Database‐NTCVR

Feng Xia, XinJing Chen, ZiLong Weng, Xin Pan, JinJun Liu, Hao Zhou, LianPin Wu, YanSong Guo, LongYan Zhang, WenZhi Pan iD, DaXin Zhou iD, JunBo Ge iD

Catheterization and Cardiovascular Interventions · 2025

DOI: 10.1002/ccd.70183 ↗

At a glance

Multizentrische Studie in Catheterization and Cardiovascular Interventions, 2025. Written by Feng Xia and 11 co-authors. Institution: Department of Cardiology, Wuhan Asia General Hospital, Wuhan, China. Major MEDLINE topics: Transcatheter Aortic Valve Replacement, Aortic Valve Insufficiency, Heart Valve Prosthesis, Aortic Valve. Cited 3 times so far (Crossref); 25 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: This study was supported by the National Natural Science Foundation of China (No. NSFC 82270377), Fujian Science and Technology Innovation Joint Funding Projec….

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Transcatheter aortic valve replacement (TAVR) for pure native aortic regurgitation (PNAR) remains challenging. While the noncoronary sinus pivot implantation (NCPI) strategy showed promise with VitaFlow valve, its efficacy with other valves needs validation.

Aims

This study aims to evaluate the real‐world efficacy of the TaurusElite valve in patients with PNAR and to assess the impact of the NCPI strategy on procedural outcomes.

Methods

This registry‐based analysis included 121 PNAR patients from the prospective CCA Database‐NTCVR who underwent transfemoral TAVR with TaurusElite valve at seven Chinese centers (April 2022 to October 2024). A core laboratory assessed procedural imaging to classify patients into NCPI ( n = 81) and non‐NCPI ( n = 37) groups. Outcomes were evaluated per VARC‐3 criteria.

Results

The TaurusElite valve demonstrated good effectiveness (overall device success 90.9%). NCPI strategy showed superior outcomes: higher success rate (98.8% vs. 81.1%, p < 0.001), no valve‐in‐valve implantation (0% vs. 16.2%, p < 0.001), and lower permanent pacemaker requirement (3.7% vs. 18.9%, p = 0.006). NCPI (OR:6.08, 95% CI: 3.27−28.68) independently predicted success.

Conclusions

The TaurusElite valve is an effective treatment for PNAR, and the NCPI strategy provides significant additional benefits in improving procedural success and reducing complications compared to conventional approaches.

Subjects

MeSH terms (MEDLINE)

Transcatheter Aortic Valve ReplacementAortic Valve InsufficiencyHeart Valve ProsthesisAortic ValveHumansMaleRegistriesFemaleTreatment OutcomeAgedAged, 80 and overProsthesis DesignDatabases, FactualTime FactorsChinaRecovery of FunctionRisk FactorsProspective Studies

Author keywords

aortic regurgitationclinical outcomesimplantation techniqueself‐expanding valvetranscatheter aortic valve replacement

Authors and institutions

  • Department of Cardiology, Wuhan Asia General Hospital, Wuhan, China.
  • Department of Cardiology, Provincial Clinical Medical College of Fujian Medical University, Fuzhou University Affiliated Provincial Hospital, Fuzhou, China.
  • Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • National Clinical Research Center for Interventional Medicine, Shanghai, China.
  • Department of Cardiology, Shanghai Chest Hospital Affiliated With Shanghai Jiao Tong University, Shanghai, China.
  • Department of Cardiology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.

ORCID profiles: WenZhi Pan, DaXin Zhou, JunBo Ge

Funding

  • This study was supported by the National Natural Science Foundation of China (No. NSFC 82270377), Fujian Science and Technology Innovation Joint Funding Projec…

Cite

APA

Xia, F., Chen, X., Weng, Z., Pan, X., Liu, J., Zhou, H., Wu, L., Guo, Y., Zhang, L., Pan, W., Zhou, D., & Ge, J. (2025). Noncoronary Sinus Pivot Implantation (NCPI) Strategy for Transcatheter Aortic Valve Replacement With Self‐Expanding Valve in Pure Native Aortic Regurgitation: A Multicenter, Registry Study From the CCA Database‐NTCVR. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70183

Vancouver

Xia F, Chen X, Weng Z, Pan X, Liu J, Zhou H, et al. Noncoronary Sinus Pivot Implantation (NCPI) Strategy for Transcatheter Aortic Valve Replacement With Self‐Expanding Valve in Pure Native Aortic Regurgitation: A Multicenter, Registry Study From the CCA Database‐NTCVR. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.70183

BibTeX
@article{Xia2025,
  author = {Xia, Feng and Chen, XinJing and Weng, ZiLong and Pan, Xin and Liu, JinJun and Zhou, Hao and Wu, LianPin and Guo, YanSong and Zhang, LongYan and Pan, WenZhi and Zhou, DaXin and Ge, JunBo},
  title = {Noncoronary Sinus Pivot Implantation (NCPI) Strategy for Transcatheter Aortic Valve Replacement With Self‐Expanding Valve in Pure Native Aortic Regurgitation: A Multicenter, Registry Study From the CCA Database‐NTCVR},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2025},
  doi = {10.1002/ccd.70183}
}
Start for free →